Also called: GPA · Wegener's Granulomatosis
Important: This page is general information, not medical advice. It does not recommend or prescribe any treatment. Always consult your doctor or pharmacist before starting, stopping or changing any medicine.
About Granulomatosis with Polyangiitis
Granulomatosis with polyangiitis (GPA), previously known as Wegener's granulomatosis, is a rare disease. It is a type of vasculitis, or inflammation of the blood vessels. The inflammation limits the flow of blood to important organs, causing damage. It can affect any organ, but it mainly affects the sinuses, nose, trachea (windpipe), lungs, and kidneys.
The cause of GPA is unknown. It can affect people at any age. Men and women are equally affected. It is more common in whites. Symptoms may include joint pain, weakness, tiredness, and cold symptoms such as a runny nose that doesn't get better. Doctors use blood tests, chest X-rays, and biopsies to diagnose GPA and rule out other causes of the symptoms.
Early treatment is important. Most people improve with medicines to slow or stop the inflammation.
It sits within Blood, Heart and Circulation, Kidneys and Urinary System and Lungs and Breathing.
The lead U.S. institute for this subject is the National Institute of Allergy and Infectious Diseases.
When to speak to someone. Reading about a topic cannot tell you whether it applies to you. Speak to a doctor or pharmacist if symptoms are severe, sudden, getting worse, or simply not going away — and seek emergency care immediately for chest pain, breathing difficulty, sudden weakness or confusion, or a serious allergic reaction.
Research on Granulomatosis with Polyangiitis
136 studies areregistered for this condition on ClinicalTrials.gov, the U.S. National Library of Medicine's public registry. A selection is below — the links go straight to the registry entry, not to a summary of ours.
What a registered study does and does not mean. Registration means a study exists and has been declared publicly. It says nothing about whether the treatment being tested works, is safe, or is available to you. Many studies find no benefit — that is what research is for. Never seek out an experimental treatment on the strength of a registry entry alone.
Research currently under way
- A Trial to Investigate Benralizumab in Children With Eosinophilic DiseasesAstraZeneca
- Safety and Immunogenicity of the Live Attenuated Tetravalent Butantan-Dengue Vaccine in Autoimmune Rheumatic DiseasesUniversity of Sao Paulo General Hospital
- Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder ArthroplastyNYU Langone Health
- Efficacy and Safety of Depemokimab Compared With Mepolizumab in Adults With Relapsing or Refractory Eosinophilic Granulomatosis With Polyangiitis (EGPA)GlaxoSmithKline
- Ocular Manifestations of Granulomatosis With Polyangiitis.Military Institute od Medicine National Research Institute
- Iptacopan in Patients With ANCA Associated VasculitisNovartis Pharmaceuticals
Research already completed
- Assessing Granulomatosis With Polyangiitis Activity: 18F-FDG PET/CT vs BVAS v3Post Graduate Institute of Medical Education and Research, Chandigarh
- Retrospective Analysis of Systemic Glucocorticoid Mediated Long-term Effects, Patient Pathways and Economic Burden Across Multiple IndicationsGlaxoSmithKline
- Effectiveness on Sino-Nasal Symptoms Of Mepolizumab 300Fondazione Policlinico Universitario Agostino Gemelli IRCCS
- Long-Term Safety and Effectiveness of Mepolizumab 300 mg in Europe (Mepo LTF Study)European EGPA Study Group
- Study of One Protein Implicated in Wegener DiseaseAssistance Publique - Hôpitaux de Paris
Study data from ClinicalTrials.gov, a service of the U.S. National Library of Medicine. Retrieved 2026-07-30. Registry entries are supplied by study sponsors and investigators; ClinicalTrials.gov does not verify their scientific validity. PocketsInfo is not affiliated with, and not endorsed by, the NLM or the NIH.
Where to read more
Rather than paraphrase, we point you to the primary sources. Every link below is to a government health agency, a national institute or a recognised medical body — grouped by what you are trying to find out.
Learn More
- Antineutrophil Cytoplasmic Antibodies (ANCA) TestNational Library of Medicine
- Cyclophosphamide (Cytoxan)Johns Hopkins Vasculitis Center
- Erythrocyte Sedimentation Rate (ESR)National Library of Medicine
- Granulomatosis with PolyangiitisJohns Hopkins Vasculitis Center
- Granulomatosis with Polyangiitis (Wegener's)American College of Rheumatology
- Granulomatosis with Polyangiitis: Symptoms and CausesMayo Foundation for Medical Education and Research
- Recommendations for GPA/MPAAmerican College of Rheumatology
Genetics
- Granulomatosis with polyangiitis: MedlinePlus GeneticsNational Library of Medicine
Clinical Trials
- ClinicalTrials.gov: Granulomatosis with PolyangiitisNational Institutes of Health
Medical subject headings
Clinicians and researchers index this subject under Granulomatosis with Polyangiitis. These are the terms to use when searching medical literature.
This page is built from the MedlinePlus health topic record for Granulomatosis with Polyangiitis, a service of the U.S. National Library of Medicine (NLM), National Institutes of Health. Information is from MedlinePlus.gov. PocketsInfo is not affiliated with, and is not endorsed by, the NLM or the NIH. Retrieved 30 July 2026.